Jiangsu Vanguard Pharmaceutical Co., Ltd.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference 94e2483eb7
Drug names110First applicant · distinct drug namesAcceptance records159First applicant · distinct acceptance numbersUnder-review numbers34First applicant · current under-review listCo-applicant records62Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
159 acceptance records as first applicant, grouped into 110 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
No verified English name 1 records · Latest accepted 2026/10/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2605191 | Supplement | 2026/10/16 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2026/09/15
Supplement · 1Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601735 | Supplement | 2026/09/15 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHL2400235 | Generic | 2024/11/23 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2400648 | Generic | 2024/02/21 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Sulindac Tablets 2 records · Latest accepted 2026/09/15
Generic · 2
Ursodeoxycholic Acid Capsules 1 records · Latest accepted 2026/08/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602164 | Generic | 2026/08/31 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Cetylpyridinium Chloride Buccal Tablets 1 records · Latest accepted 2026/07/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601658 | Generic | 2026/07/10 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Sacubitril Valsartan Sodium Tablets 6 records · Latest accepted 2026/07/08
Supplement · 2Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601287 | Supplement | 2026/07/08 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2601286 | Supplement | 2026/07/08 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2501071 | Generic | 2025/03/14 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2501070 | Generic | 2025/03/14 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2303500 | Generic | 2023/12/19 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2303499 | Generic | 2023/12/19 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Mecobalamin Tablets 1 records · Latest accepted 2026/07/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601610 | Generic | 2026/07/07 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/06/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601530 | Generic | 2026/06/29 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Chloroprocaine Hydrochloride Injection 2 records · Latest accepted 2026/06/11
Generic · 2
Atorvastatin Calcium Tablets 2 records · Latest accepted 2026/06/11
Generic · 2
No verified English name 1 records · Latest accepted 2026/05/26
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2602313 | Supplement | 2026/05/26 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Loratadine Tablets 1 records · Latest accepted 2026/05/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601192 | Generic | 2026/05/25 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/05/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2602227 | Supplement | 2026/05/22 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/05/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2602114 | Supplement | 2026/05/18 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Edaravone and Dexborneol Concentrated Solution for Injection 1 records · Latest accepted 2026/05/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601155 | Generic | 2026/05/14 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Vonoprazan Fumarate Tablets 4 records · Latest accepted 2026/05/12
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600903 | Supplement | 2026/05/12 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2600902 | Supplement | 2026/05/12 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2301632 | Generic | 2023/06/15 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2301631 | Generic | 2023/06/15 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Loxoprofen Sodium Patches 2 records · Latest accepted 2026/04/28
Generic · 2
No verified English name 1 records · Latest accepted 2026/04/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2601595 | Supplement | 2026/04/23 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Tadalafil Tablets 3 records · Latest accepted 2026/04/03
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600780 | Generic | 2026/04/03 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2600779 | Generic | 2026/04/03 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2600778 | Generic | 2026/04/03 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
6-[18F]Fluoro-L-DOPA Injection 1 records · Latest accepted 2026/01/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2600010 | Generic | 2026/01/14 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/01/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600122 | Generic | 2026/01/09 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Upadacitinib Sustained-release Tablets 1 records · Latest accepted 2025/12/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504513 | Generic | 2025/12/31 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/12/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504476 | Generic | 2025/12/30 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Argatroban Injection 2 records · Latest accepted 2025/12/24
Supplement · 2
Losartan Potassium Tablets 2 records · Latest accepted 2025/12/17
Generic · 2
Sildenafil Citrate Tablets 4 records · Latest accepted 2025/11/21
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504026 | Generic | 2025/11/21 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2504025 | Generic | 2025/11/21 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2102191 | Generic | 2021/12/14 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2102190 | Generic | 2021/12/14 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/11/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2502611 | Supplement | 2025/11/13 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/11/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2502591 | Supplement | 2025/11/12 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Amlodipine Besylate Tablets 1 records · Latest accepted 2025/11/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503870 | Generic | 2025/11/05 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Valsartan Capsules 1 records · Latest accepted 2025/10/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503647 | Generic | 2025/10/14 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Mupirocin Ointment 3 records · Latest accepted 2025/10/09
Supplement · 2Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501965 | Supplement | 2025/10/09 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501964 | Supplement | 2025/10/09 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2300028 | Generic | 2023/01/05 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Olopatadine Hydrochloride Eye Drops 2 records · Latest accepted 2025/09/23
Generic · 2
Calcitriol Soft Capsules 1 records · Latest accepted 2025/08/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502992 | Generic | 2025/08/15 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Baricitinib Tablets 2 records · Latest accepted 2025/08/13
Generic · 2
Phloroglucinol Injection 2 records · Latest accepted 2025/07/30
Supplement · 1Generic · 1
No verified English name 1 records · Latest accepted 2025/07/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502718 | Generic | 2025/07/28 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/07/25
New drug · 1Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2500085 | New drug | 2025/07/25 | Jiangsu Vanguard Pharmaceutical Co., Ltd.; Guangdong Sunho Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2200051 | Supplement | 2022/03/28 | Jiangsu Vanguard Pharmaceutical Co., Ltd.; Guangdong Sunho Pharmaceutical Co., Ltd. | CDE ↗ |
Ebastine Oral Solution 1 records · Latest accepted 2025/07/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502684 | Generic | 2025/07/24 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Oseltamivir Phosphate Capsules 3 records · Latest accepted 2025/07/01
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502329 | Generic | 2025/07/01 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2502328 | Generic | 2025/07/01 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2502327 | Generic | 2025/07/01 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Clopidogrel Bisulfate and Aspirin Tablets 1 records · Latest accepted 2025/06/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502064 | Generic | 2025/06/11 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Saxagliptin Tablets 1 records · Latest accepted 2025/05/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501847 | Generic | 2025/05/22 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Clopidogrel Hydrogen Sulphate Tablets 1 records · Latest accepted 2025/04/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501579 | Generic | 2025/04/26 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Diclofenac Sodium Sustained Release Tablets 1 records · Latest accepted 2025/04/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501252 | Generic | 2025/04/03 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/03/01
Generic · 2
Trazodone Hydrochloride Tablets 2 records · Latest accepted 2025/02/14
Generic · 2
Sodium Hyaluronate Eye Drops 2 records · Latest accepted 2025/02/12
Generic · 2
No verified English name 3 records · Latest accepted 2024/12/27
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404573 | Generic | 2024/12/27 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHL2400236 | Generic | 2024/11/26 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2301698 | Generic | 2023/06/27 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) 1 records · Latest accepted 2024/12/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404592 | Generic | 2024/12/27 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/12/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404591 | Generic | 2024/12/27 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/12/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404515 | Generic | 2024/12/25 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/11/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404109 | Generic | 2024/11/29 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Trazodone Hydrochloride Sustained-release Tablets 2 records · Latest accepted 2024/11/27
Generic · 2
Ferrous Succinate Tablets 1 records · Latest accepted 2024/11/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403926 | Generic | 2024/11/15 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Bisoprolol Fumarate and Amlodipine Besylate Tablets 1 records · Latest accepted 2024/11/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403889 | Generic | 2024/11/13 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/11/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450561 | Supplement | 2024/11/09 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2024/10/08
Generic · 2
Iguratimod Tablets 1 records · Latest accepted 2024/09/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403191 | Generic | 2024/09/25 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Diquafosol Sodium Eye Drops 2 records · Latest accepted 2024/09/21
Generic · 2
No verified English name 1 records · Latest accepted 2024/09/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403064 | Generic | 2024/09/13 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Iron Proteinsuccinylate Oral Solution 1 records · Latest accepted 2024/09/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403030 | Generic | 2024/09/11 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Ethyl Iosapentate Capsules 1 records · Latest accepted 2024/08/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402773 | Generic | 2024/08/24 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/06/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401936 | Generic | 2024/06/28 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Rupatadine Fumarate Tablets 1 records · Latest accepted 2024/06/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400771 | Supplement | 2024/06/06 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Olopatadine Hydrochloride Granules 1 records · Latest accepted 2024/06/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400772 | Supplement | 2024/06/06 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Lactulose Oral Solution 2 records · Latest accepted 2024/05/30
Generic · 2
No verified English name 1 records · Latest accepted 2024/05/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401385 | Generic | 2024/05/10 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Choline Fenofibrate Sustained-release Capsules 2 records · Latest accepted 2024/04/18
Generic · 2
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets 1 records · Latest accepted 2024/04/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400992 | Generic | 2024/04/02 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets 1 records · Latest accepted 2024/04/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400993 | Generic | 2024/04/02 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Vardenafil Hydrochloride Tablets 2 records · Latest accepted 2024/04/01
Generic · 2
Lidocaine and Tetracaine Cream 1 records · Latest accepted 2024/03/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2400063 | Generic | 2024/03/23 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Crisaborole Ointment 1 records · Latest accepted 2024/02/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400540 | Generic | 2024/02/07 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Levofloxacin Eye Drops 1 records · Latest accepted 2024/01/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400357 | Generic | 2024/01/26 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Dapagliflozin Tablets 2 records · Latest accepted 2024/01/23
Generic · 2
Nifuratel And Nystatin Vaginal Soft Capsules 1 records · Latest accepted 2023/12/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2300169 | Generic | 2023/12/30 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Progesterone Sustained-release Vaginal Gel 1 records · Latest accepted 2023/12/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303533 | Generic | 2023/12/20 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2023/12/09
Generic · 2
Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution 1 records · Latest accepted 2023/09/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302438 | Generic | 2023/09/11 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/08/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302320 | Generic | 2023/08/30 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/08/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302105 | Generic | 2023/08/15 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Ambroxol Hydrochloride Oral Solution 3 records · Latest accepted 2023/08/15
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302109 | Generic | 2023/08/15 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2302107 | Generic | 2023/08/15 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101561 | Generic | 2021/08/17 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/08/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302104 | Generic | 2023/08/14 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Procaterol Hydrochloride Oral Solution 1 records · Latest accepted 2023/07/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301818 | Generic | 2023/07/06 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Diacerein Capsules 1 records · Latest accepted 2023/07/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301785 | Generic | 2023/07/04 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Perampanel Tablets 2 records · Latest accepted 2023/06/27
Generic · 2
Omega-3-acid ethyl ester 90 Soft Capsules 1 records · Latest accepted 2023/05/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301245 | Generic | 2023/05/09 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Fluvoxamine Maleate Tablets 1 records · Latest accepted 2023/04/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301186 | Generic | 2023/04/28 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Pranoprofen Eye Drops 1 records · Latest accepted 2023/04/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300973 | Generic | 2023/04/05 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/04/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300948 | Generic | 2023/04/01 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/12/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2202138 | Generic | 2022/12/29 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Aspirin Enteric-coated Tablets 1 records · Latest accepted 2022/09/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201656 | Generic | 2022/09/30 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Nintedanib Esilate Soft Capsules 2 records · Latest accepted 2022/09/15
Generic · 2
No verified English name 1 records · Latest accepted 2022/07/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201153 | Generic | 2022/07/29 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Dapoxetine Hydrochloride Tablets 1 records · Latest accepted 2022/07/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201054 | Generic | 2022/07/12 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Glucosamine Sulfate Capsules 1 records · Latest accepted 2022/07/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201043 | Generic | 2022/07/11 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Minoxidil Topical Solution 2 records · Latest accepted 2022/06/13
Generic · 2
Alendronate Sodium Tablets 1 records · Latest accepted 2022/06/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200854 | Generic | 2022/06/09 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Moxifloxacin Hydrochloride Eye Drops 2 records · Latest accepted 2022/05/06
Generic · 2
Ivabradine Hydrochloride Tablets 1 records · Latest accepted 2022/04/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200625 | Generic | 2022/04/21 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Oseltamivir Phosphate For Oral Suspension 1 records · Latest accepted 2022/04/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200593 | Generic | 2022/04/14 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Bromfenac Sodium Eye Drops 1 records · Latest accepted 2022/04/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200517 | Generic | 2022/04/01 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Olmesartan Medoxomil and Amlodipine Besylate Tablets 1 records · Latest accepted 2022/01/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200144 | Generic | 2022/01/24 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/12/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102213 | Generic | 2021/12/16 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Rocuronium Bromide Injection 1 records · Latest accepted 2021/11/24
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2140540 | Supplement | 2021/11/24 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Olmesartan Medoxomil and Hydrochlorothiazide Tablets 1 records · Latest accepted 2021/09/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101718 | Generic | 2021/09/14 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Paracetamol and Caffeine Tablets 1 records · Latest accepted 2021/08/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101600 | Generic | 2021/08/17 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Sugammadex Sodium Injection 2 records · Latest accepted 2021/07/08
Generic · 2
Dutasteride Soft Capsules 1 records · Latest accepted 2021/04/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101060 | Generic | 2021/04/14 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Valsartan and Amlodipine Tablets（I） 1 records · Latest accepted 2021/03/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100277 | Generic | 2021/03/12 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/01/28
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2100029 | New drug | 2021/01/28 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
13 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 5 applicationsNo longer listed under review: 6 applicationsSupplement delivery: 2 applications
- 2026/11/11No longer listed under review
Oseltamivir Phosphate Capsules
CYHS2502329
Fact date: 2026/11/11 · Site observation date: 2026/11/11
Accepted: 2025/07/01
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/11No longer listed under review
Oseltamivir Phosphate Capsules
CYHS2502328
Fact date: 2026/11/11 · Site observation date: 2026/11/11
Accepted: 2025/07/01
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/11No longer listed under review
Oseltamivir Phosphate Capsules
CYHS2502327
Fact date: 2026/11/11 · Site observation date: 2026/11/11
Accepted: 2025/07/01
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/04No longer listed under review
No verified English name
CYHS2502718
Fact date: 2026/11/04 · Site observation date: 2026/11/04
Accepted: 2025/07/28
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/10/31No longer listed under review
Sacubitril Valsartan Sodium Tablets
CYHB2601287
Fact date: 2026/10/31 · Site observation date: 2026/10/31
Accepted: 2026/07/08
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/30 (approval no.: —; approval date: 2026/10/29); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 5
NMPA · Table row 5 ↗ View source ↗ - 2026/10/31No longer listed under review
Sacubitril Valsartan Sodium Tablets
CYHB2601286
Fact date: 2026/10/31 · Site observation date: 2026/10/31
Accepted: 2026/07/08
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/30 (approval no.: —; approval date: 2026/10/29); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 4
NMPA · Table row 4 ↗ View source ↗ - 2026/10/29Supplement delivery
Sacubitril Valsartan Sodium Tablets
CYHB2601287
Fact date: 2026/10/29 · Publication date: 2026/10/30 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 5 ↗ - 2026/10/29Supplement delivery
Sacubitril Valsartan Sodium Tablets
CYHB2601286
Fact date: 2026/10/29 · Publication date: 2026/10/30 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 4 ↗ - 2026/10/16Accepted
No verified English name
CYZB2605191
Fact date: 2026/10/16 · Site observation date: 2026/10/21
View source ↗ - 2026/09/15Accepted
Sulindac Tablets
CYHS2602279
Fact date: 2026/09/15 · Site observation date: 2026/10/21
View source ↗ - 2026/09/15Accepted
Sulindac Tablets
CYHS2602278
Fact date: 2026/09/15 · Site observation date: 2026/10/21
View source ↗ - 2026/09/15Accepted
No verified English name
CYHB2601735
Fact date: 2026/09/15 · Site observation date: 2026/10/21
View source ↗ - 2026/08/31Accepted
Ursodeoxycholic Acid Capsules
CYHS2602164
Fact date: 2026/08/31 · Site observation date: 2026/10/21
View source ↗
Under review
34 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | CYZB2605191 | Supplement | 2026/10/16 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Sulindac Tablets | CYHS2602279 | Generic | 2026/09/15 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Sulindac Tablets | CYHS2602278 | Generic | 2026/09/15 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2601735 | Supplement | 2026/09/15 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Ursodeoxycholic Acid Capsules | CYHS2602164 | Generic | 2026/08/31 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Cetylpyridinium Chloride Buccal Tablets | CYHS2601658 | Generic | 2026/07/10 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Mecobalamin Tablets | CYHS2601610 | Generic | 2026/07/07 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2601530 | Generic | 2026/06/29 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Chloroprocaine Hydrochloride Injection | CYHS2601393 | Generic | 2026/06/11 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Chloroprocaine Hydrochloride Injection | CYHS2601392 | Generic | 2026/06/11 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Atorvastatin Calcium Tablets | CYHS2601378 | Generic | 2026/06/11 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Atorvastatin Calcium Tablets | CYHS2601377 | Generic | 2026/06/11 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Loratadine Tablets | CYHS2601192 | Generic | 2026/05/25 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Edaravone and Dexborneol Concentrated Solution for Injection | CYHS2601155 | Generic | 2026/05/14 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Loxoprofen Sodium Patches | CYHS2600980 | Generic | 2026/04/28 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Loxoprofen Sodium Patches | CYHS2600979 | Generic | 2026/04/28 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Tadalafil Tablets | CYHS2600780 | Generic | 2026/04/03 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Tadalafil Tablets | CYHS2600779 | Generic | 2026/04/03 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Tadalafil Tablets | CYHS2600778 | Generic | 2026/04/03 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2600122 | Generic | 2026/01/09 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Upadacitinib Sustained-release Tablets | CYHS2504513 | Generic | 2025/12/31 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2504476 | Generic | 2025/12/30 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Losartan Potassium Tablets | CYHS2504306 | Generic | 2025/12/17 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Losartan Potassium Tablets | CYHS2504305 | Generic | 2025/12/17 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Sildenafil Citrate Tablets | CYHS2504026 | Generic | 2025/11/21 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Sildenafil Citrate Tablets | CYHS2504025 | Generic | 2025/11/21 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Amlodipine Besylate Tablets | CYHS2503870 | Generic | 2025/11/05 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Valsartan Capsules | CYHS2503647 | Generic | 2025/10/14 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Calcitriol Soft Capsules | CYHS2502992 | Generic | 2025/08/15 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Baricitinib Tablets | CYHS2502940 | Generic | 2025/08/13 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Baricitinib Tablets | CYHS2502939 | Generic | 2025/08/13 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CXHS2500085 | New drug | 2025/07/25 | Jiangsu Vanguard Pharmaceutical Co., Ltd.; Guangdong Sunho Pharmaceutical Co., Ltd. | CDE ↗ |
| Ebastine Oral Solution | CYHS2502684 | Generic | 2025/07/24 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Iron Proteinsuccinylate Oral Solution | CYHS2403030 | Generic | 2024/09/11 | Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
55 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Clopidogrel Hydrogen Sulphate Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20266055 | 2026/09/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Trazodone Hydrochloride Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20265850 | 2026/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Trazodone Hydrochloride Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20265849 | 2026/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ferrous Succinate Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20265019 | 2026/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264914 | 2026/06/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264915 | 2026/06/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Diclofenac Sodium Sustained Release Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264648 | 2026/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264489 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264490 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Trazodone Hydrochloride Sustained-release Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20263907 | 2026/04/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Trazodone Hydrochloride Sustained-release Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20263908 | 2026/04/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ethyl Iosapentate Capsules | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20263744 | 2026/03/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bisoprolol Fumarate and Amlodipine Besylate Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20263116 | 2026/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20256383 | 2025/12/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iguratimod Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20256193 | 2025/12/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20255334 | 2025/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Choline Fenofibrate Sustained-release Capsules | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20254219 | 2025/05/20 | Not stated by source | CDE ↗ |
| Choline Fenofibrate Sustained-release Capsules | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20254220 | 2025/05/20 | Not stated by source | CDE ↗ |
| Saxagliptin and Metformin Hydrochloride Sustained-release Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20254115 | 2025/05/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Saxagliptin and Metformin Hydrochloride Sustained-release Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20254116 | 2025/05/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vardenafil Hydrochloride Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20254130 | 2025/05/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vardenafil Hydrochloride Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20254129 | 2025/05/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20253841 | 2025/04/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20253768 | 2025/04/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20253767 | 2025/04/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Omega-3-acid ethyl ester 90 Soft Capsules | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20244905 | 2024/09/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Perampanel Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20244857 | 2024/09/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Perampanel Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20244858 | 2024/09/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluvoxamine Maleate Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20244559 | 2024/07/30 | Not stated by source | CDE ↗ |
| Aspirin Enteric-coated Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20243166 | 2024/02/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nintedanib Esilate Soft Capsules | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20243030 | 2024/01/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nintedanib Esilate Soft Capsules | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20243031 | 2024/01/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Glucosamine Sulfate Capsules | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20234453 | 2023/10/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ivabradine Hydrochloride Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20234309 | 2023/10/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Alendronate Sodium Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20234225 | 2023/09/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dutasteride Soft Capsules | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20234210 | 2023/09/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20234149 | 2023/09/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Phloroglucinol Injection | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20234121 | 2023/09/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20233975 | 2023/08/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olmesartan Medoxomil and Amlodipine Besylate Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20233880 | 2023/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paracetamol and Caffeine Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20233007 | 2023/01/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olmesartan Medoxomil and Hydrochlorothiazide Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20223891 | 2022/11/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Valsartan and Amlodipine Tablets（I） | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20223379 | 2022/06/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Hydrotalcite Chewable Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20067319 | 2022/01/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sarpogrelate Hydrochloride Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20213701 | 2021/09/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20093243 | 2021/09/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20080288 | 2021/06/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Valsartan and Hydrochlorothiazide Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20213285 | 2021/04/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20213255 | 2021/04/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Calcium Dobesilate Capsules | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203548 | 2020/11/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levetiracetam Concentrated Solution for Injection | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203521 | 2020/10/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | 2020/09/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Montelukast Sodium Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203308 | 2020/07/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Saxagliptin Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20266286 | 2026/10/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Clopidogrel Bisulfate and Aspirin Tablets | Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20266217 | 2026/10/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
62 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Ethyl Iosapentate Capsules | CYHS2601680 | Generic | 2026/07/15 | Jiangsu Lianhuan Pharmaceutical Co.,Ltd.; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Ethyl Iosapentate Capsules | CYHS2601679 | Generic | 2026/07/15 | Jiangsu Lianhuan Pharmaceutical Co.,Ltd.; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHB2601349 | Supplement | 2026/07/15 | Topfond Pharmaceutical Co., Ltd.; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHB2601348 | Supplement | 2026/07/15 | Topfond Pharmaceutical Co., Ltd.; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Dutasteride Soft Capsules | CYHB2600923 | Supplement | 2026/05/14 | Jiangsu Ziyond Pharmaceutical Co., Ltd.; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Montelukast Sodium Tablets | CYHS2601037 | Generic | 2026/05/08 | Hainan Wan Wei Pharmaceutical Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Olopatadine Hydrochloride Tablets | CYHS2600595 | Generic | 2026/03/02 | Hainan Wan Wei Pharmaceutical Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Nintedanib Esilate Soft Capsules | CYHB2502314 | Supplement | 2025/11/08 | Beijing Kang Di Ni Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Nintedanib Esilate Soft Capsules | CYHB2502313 | Supplement | 2025/11/08 | Beijing Kang Di Ni Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Vardenafil Hydrochloride Tablets | CYHS2502734 | Generic | 2025/07/30 | Hangzhou Min Sheng Drug Research Institute Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Vardenafil Hydrochloride Tablets | CYHS2502733 | Generic | 2025/07/30 | Hangzhou Min Sheng Drug Research Institute Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Nifuratel And Nystatin Vaginal Soft Capsules | CYHS2502706 | Generic | 2025/07/28 | Hainan Wan Wei Pharmaceutical Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2502411 | Generic | 2025/07/08 | Zhong Xi (Fujian) Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Nintedanib Esilate Soft Capsules | CYHB2500424 | Supplement | 2025/03/03 | Beijing Kang Di Ni Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Nintedanib Esilate Soft Capsules | CYHB2500423 | Supplement | 2025/03/03 | Beijing Kang Di Ni Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Vonoprazan Fumarate Tablets | CYHS2404582 | Generic | 2024/12/27 | Zhong Xi (Fujian) Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Vonoprazan Fumarate Tablets | CYHS2404581 | Generic | 2024/12/27 | Zhong Xi (Fujian) Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHB2401934 | Supplement | 2024/11/20 | Topfond Pharmaceutical Co., Ltd.; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Sacubitril Valsartan Sodium Tablets | CYHB2401933 | Supplement | 2024/11/20 | Topfond Pharmaceutical Co., Ltd.; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Crisaborole Ointment | CYHS2403951 | Generic | 2024/11/18 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2401860 | Supplement | 2024/11/09 | Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2401859 | Supplement | 2024/11/09 | Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Calcitriol Soft Capsules | CYHS2402969 | Generic | 2024/09/10 | Guangdong Wen Jian Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Minoxidil Topical Solution | CYHS2402603 | Generic | 2024/08/12 | Jiangsu Ji Ming Pharmaceuticals Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Minoxidil Topical Solution | CYHS2402602 | Generic | 2024/08/12 | Jiangsu Ji Ming Pharmaceuticals Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Lurasidone Hydrochloride Tablets | CYHS2402385 | Generic | 2024/07/29 | Hunan Qian Jin Xiang Jiang Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2401072 | Supplement | 2024/07/19 | Guangzhou Shi Lian Rui Pharmaceutical Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Aspirin Enteric-coated Tablets | CYHS2401526 | Generic | 2024/05/22 | Jiangsu Ji Ming Pharmaceuticals Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Miconazole Nitrate Vaginal Soft Capsules | CYHB2400681 | Supplement | 2024/05/21 | SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Miconazole Nitrate Vaginal Soft Capsules | CYHB2400680 | Supplement | 2024/05/21 | SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Eldecalcitol Soft Capsules | CYHS2303159 | Generic | 2023/11/17 | Guangdong Jiang Zheng Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Eldecalcitol Soft Capsules | CYHS2303158 | Generic | 2023/11/17 | Guangdong Jiang Zheng Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2303047 | Generic | 2023/11/08 | Jiangsu Ji Ming Pharmaceuticals Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2302455 | Supplement | 2023/11/08 | Nanjing Ming Sheng Pharmaceuticals Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Ivabradine Hydrochloride Tablets | CYHB2302421 | Supplement | 2023/11/01 | Hainan Tong Yong San Yang Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Dapoxetine Hydrochloride Tablets | CYHB2302211 | Supplement | 2023/10/09 | Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2302099 | Supplement | 2023/09/16 | SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2301971 | Supplement | 2023/09/02 | SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2302283 | Generic | 2023/08/28 | Wei Sheng Yuan (Xiamen) Bio Technology Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | CYHS2301932 | Generic | 2023/07/18 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Phloroglucinol Injection | CYHS2301568 | Generic | 2023/06/08 | Beijing Bai Ao Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution | CYHS2301214 | Generic | 2023/05/05 | Wei Sheng Yuan (Xiamen) Bio Technology Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYZB2300502 | Supplement | 2023/03/24 | Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYZB2300501 | Supplement | 2023/03/24 | Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYZB2300500 | Supplement | 2023/03/24 | Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Ambroxol Hydrochloride Oral Solution | CYHB2300599 | Supplement | 2023/03/24 | SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Rupatadine Fumarate Tablets | CYHS2300772 | Generic | 2023/03/13 | Name not romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Sildenafil Citrate Tablets | CYHB2300501 | Supplement | 2023/03/08 | Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Sildenafil Citrate Tablets | CYHB2300500 | Supplement | 2023/03/08 | Guangdong Quan Xin Quan Yi Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Minoxidil Topical Solution | CYHS2300091 | Generic | 2023/01/11 | Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Minoxidil Topical Solution | CYHS2300090 | Generic | 2023/01/11 | Jiang You Pharmaceutical (Chang De) Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Olopatadine Hydrochloride Granules | CYHS2202150 | Generic | 2022/12/30 | Nanjing Ming Sheng Pharmaceuticals Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Entacapone Tablets | CYHS2202051 | Generic | 2022/12/10 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Calcitriol Soft Capsules | CYHS2201535 | Generic | 2022/09/16 | Jiangsu Zhong Zhi Pharmaceutical Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Argatroban Injection | CYHB2201581 | Supplement | 2022/09/02 | Tai Yang Sheng (Bo Zhou) Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Thioctic Acid Injection | CYHB2201580 | Supplement | 2022/09/02 | Tai Yang Sheng (Bo Zhou) Biopharmaceuticals Technology Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2201161 | Generic | 2022/07/28 | Sui Cheng Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Phloroglucinol Injection | CYHS2200491 | Generic | 2022/03/25 | Shou Guang Fu Kang Pharmaceutical Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Amisulpride Tablets | CYHS2200205 | Generic | 2022/01/27 | Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Aminocaproic Acid Injection | CYHB2150745 | Supplement | 2021/07/20 | Beijing Bai Ao Pharma Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Thioctic Acid Injection | CYHB2101308 | Supplement | 2021/05/27 | Bo Zhou Wan Nuo Pharmaceuticals Technology Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
| Argatroban Injection | CYHB2101307 | Supplement | 2021/05/27 | Bo Zhou Wan Nuo Pharmaceuticals Technology Co., Ltd. romanized; Jiangsu Vanguard Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.